Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Between Bedside and Bench
  • Published:

Inside the microbial and immune labyrinth: Totally gutted

In Crohn's disease, immune damage to the gut wall is both induced and modified by the gut microflora, challenging researchers to solve the maze of interactions exploitable for therapeutic benefit. Whether these microbial 'guests' are worsening or helping in this scenario is still open to debate. In 'Bench to Bedside', Warren Strober highlights mice studies showing that certain microbes in the gut have a protective role promoting a shift towards an increased regulatory response that protects from recurrence of the disease. In 'Bedside to Bench', Thomas MacDonald examines how human studies using strategies to block soluble proinflammatory cytokines—despite solid supporting data from animal models—have shown disappointing results compared with therapies that neutralize soluble cytokines but also deplete proinflammatory cells, calling into question whether targeting a single soluble cytokine will ever be useful to treat people with Crohn's disease.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The cytokine milieu in Crohn's disease is complex and a challenge for researchers to inhibit with single-target agents.

References

  1. MacDonald, T.T. & Monteleone, G. Science 307, 1920–1925 (2005).

    Article  CAS  Google Scholar 

  2. Hommes, D.W. et al. Gut 55, 1131–1137 (2006).

    Article  CAS  Google Scholar 

  3. Reinisch, W. et al. Gut 55, 1138–1144 (2006).

    Article  CAS  Google Scholar 

  4. Reinisch, W. et al. Inflamm. Bowel Dis. 16, 233–242 (2010).

    Article  Google Scholar 

  5. Sandborn, W.J. et al. Gastroenterology 135, 1130–1141 (2008).

    Article  CAS  Google Scholar 

  6. Mannon, P.J. et al. N. Engl. J. Med. 351, 2069–2079 (2004).

    Article  CAS  Google Scholar 

  7. Colombel, J.F. et al. N. Engl. J. Med. 362, 1383–1395 (2010).

    Article  CAS  Google Scholar 

  8. Rovedatti, L. et al. Gut 58, 1629–1636 (2009).

    Article  CAS  Google Scholar 

  9. Nesbitt, A. et al. Inflamm. Bowel Dis. 13, 1323–1332 (2007).

    Article  Google Scholar 

  10. Atreya, R. et al. Nat. Med. 6, 583–588 (2000).

    Article  CAS  Google Scholar 

  11. Ito, H. et al. Gastroenterology 126, 989–996 (2004).

    Article  CAS  Google Scholar 

  12. MacDonald, T.T. & Monteleone, G. in Inflammatory Bowel Disease (eds. Targan, S.R., Shanahan, F. & Carp, L.C.) 82–91 (Wiley Blackwell, Oxford, UK, 2010).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas T MacDonald.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

MacDonald, T. Inside the microbial and immune labyrinth: Totally gutted. Nat Med 16, 1194–1195 (2010). https://doi.org/10.1038/nm1110-1194

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1110-1194

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research